Description
In this presentation, Robert Ashford discusses the BOAST (British Orthopedic Association Standards for Trauma) initiative, aiming to improve standards in the management of metastatic bone disease. He opens by introducing BOOS (British Orthopedic Oncology Society) and promoting next year's meeting, which will focus exclusively on metastatic bone disease. Ashford elaborates on the historical context of guidelines related to metastatic disease, referencing previous works by BASO and BOA. He highlights significant findings from a recent audit showcasing low compliance rates in essential management protocols for metastatic conditions, underlining a pressing need for improved standards and practices.
The presentation defines key terms and outlines the importance of meticulous documentation and auditable standards in patient management. Ashford stresses that suspected metastatic bone disease demands an organized approach to patient care, involving multidisciplinary collaboration and rapid referrals to appropriate centers for suspected malignancies. He emphasizes the need for immediate assessment and referral pathways, particularly urging that biopsies should only be performed at specialized bone sarcoma centers.
Furthermore, he explains the necessity of clear documentation regarding treatment decisions and patient involvement in their care plans. As Ashford concludes, he calls for educational efforts to raise awareness of BOAST standards to ensure better clinical outcomes for patients with metastatic bone disease.